Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jan-Jun;14(1):1-4.
doi: 10.5005/jp-journals-10018-1424.

Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name?

Shivaram P Singh  1 , K C Sudhamshu  2 , Prajna Anirvan  1 , Ananta Shrestha  3 , Mamun Al Mahtab  4
Affiliations
Editorial

Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name?

Shivaram P Singh et al. Euroasian J Hepatogastroenterol. 2024 Jan-Jun.

Abstract

How to cite this article: Singh SP, Sudhamshu KC, Anirvan P, et al. Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name? Euroasian J Hepato-Gastroenterol 2024;14(1):1-4.

Keywords: Alcohol; Fatty liver disease; Nomenclature; Prevention; South Asia; Steatotic liver disease; Stigma.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: Dr. Ananta Shrestha and Dr. Mamun Al Mahtab are associated as the Editorial board members of this journal and this manuscript was subjected to this journal's standard review procedures, with this peer review handled independently of these Editorial board members and their research group.

References

    1. Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851–861. doi: 10.1016/s2468-1253(22)00165-0. - DOI - PubMed
    1. Wang D, Xu Y, Zhu Z, et al. Changes in the global, regional, and national burdens of NAFLD from 1990 to 2019: A systematic analysis of the global burden of disease study 2019. Front Nutr. 2022;9:1047129. doi: 10.3389/fnut.2022.1047129. - DOI - PMC - PubMed
    1. Chen H, Zhan Y, Zhang J, et al. The global, regional, and national burden and trends of NAFLD in 204 countries and territories: An analysis from global burden of disease 2019. JMIR Public Health Surveill. 2022;8(12):e34809. doi: 10.2196/34809. - DOI - PMC - PubMed
    1. Blais P, Husain N, Kramer JR, et al. Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol. 2015;110(1):10–14. doi: 10.1038/ajg.2014.134. - DOI - PubMed
    1. Alexander M, Loomis AK, Fairburn–Beech J, et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC Med. 2018;16(1):130. doi: 10.1186/s12916-018-1103-x. - DOI - PMC - PubMed

Publication types

LinkOut - more resources